Nasrat Hakim | Chairman, CEO & President |
Carter Ward | CFO, Secretary & Treasurer |
Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals conference call. [Operator Instructions].
Before management begins speaking, the company has the following statements. This conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to the effects, if any, of the results, performances or other expectations that may have some correlation to the subject matter of this conference call. Listeners are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, Elite's ability to obtain FDA approval of the transfers of the ANDAs or the timing of such approval processes, delays, uncertainties and ability to obtain necessary ingredients and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performances or other expectations that may be implied by these forward-looking statements.